These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 1813972

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Motor fluctuations in Parkinson's disease: pathogenetic and therapeutic studies.
    Mouradian MM, Juncos JL, Fabbrini G, Chase TN.
    Ann Neurol; 1987 Oct; 22(4):475-9. PubMed ID: 3435068
    [Abstract] [Full Text] [Related]

  • 5. Nighttime levodopa infusions to treat motor fluctuations in advanced Parkinson's disease: preliminary observations.
    Sage JI, Mark MH.
    Ann Neurol; 1991 Oct; 30(4):616-7. PubMed ID: 1789688
    [Abstract] [Full Text] [Related]

  • 6. Motor fluctuations during continuous levodopa infusions in patients with Parkinson's disease.
    Nutt JG, Carter JH, Lea ES, Woodward WR.
    Mov Disord; 1997 May; 12(3):285-92. PubMed ID: 9159720
    [Abstract] [Full Text] [Related]

  • 7. The rationale for continuous dopaminergic stimulation in patients with Parkinson's disease.
    Sage JI, Mark MH.
    Neurology; 1992 Jan; 42(1 Suppl 1):23-8; discussion 57-60. PubMed ID: 1347908
    [Abstract] [Full Text] [Related]

  • 8. Wearing-off fluctuations in Parkinson's disease: contribution of postsynaptic mechanisms.
    Bravi D, Mouradian MM, Roberts JW, Davis TL, Sohn YH, Chase TN.
    Ann Neurol; 1994 Jul; 36(1):27-31. PubMed ID: 8024257
    [Abstract] [Full Text] [Related]

  • 9. Pathogenesis of dyskinesias in Parkinson's disease.
    Mouradian MM, Heuser IJ, Baronti F, Fabbrini G, Juncos JL, Chase TN.
    Ann Neurol; 1989 May; 25(5):523-6. PubMed ID: 2774496
    [Abstract] [Full Text] [Related]

  • 10. Clinical aspects of motor fluctuations in Parkinson's disease.
    Poewe WH.
    Neurology; 1994 Jul; 44(7 Suppl 6):S6-9. PubMed ID: 8047260
    [Abstract] [Full Text] [Related]

  • 11. Pulsatile stimulation of dopamine receptors and levodopa-induced motor complications in Parkinson's disease: implications for the early use of COMT inhibitors.
    Olanow CW, Obeso JA.
    Neurology; 2000 Jul; 55(11 Suppl 4):S72-7; discussion S78-81. PubMed ID: 11147513
    [Abstract] [Full Text] [Related]

  • 12. Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's disease.
    Olanow CW, Obeso JA, Stocchi F.
    Nat Clin Pract Neurol; 2006 Jul; 2(7):382-92. PubMed ID: 16932589
    [Abstract] [Full Text] [Related]

  • 13. Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease.
    Vaamonde J, Luquin MR, Obeso JA.
    Mov Disord; 1990 Jul; 5(3):260-2. PubMed ID: 2388647
    [Abstract] [Full Text] [Related]

  • 14. Treatment of Parkinson's disease.
    Lieberman A.
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):339-43. PubMed ID: 8507903
    [Abstract] [Full Text] [Related]

  • 15. The significance of continuous dopaminergic stimulation in the treatment of Parkinson's disease.
    Chase TN.
    Drugs; 1998 Jun; 55 Suppl 1():1-9. PubMed ID: 9483164
    [Abstract] [Full Text] [Related]

  • 16. Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's disease.
    Fabbrini G, Juncos J, Mouradian MM, Serrati C, Chase TN.
    Ann Neurol; 1987 Apr; 21(4):370-6. PubMed ID: 3579222
    [Abstract] [Full Text] [Related]

  • 17. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part II.
    Mouradian MM, Juncos JL, Fabbrini G, Schlegel J, Bartko JJ, Chase TN.
    Ann Neurol; 1988 Sep; 24(3):372-8. PubMed ID: 3228271
    [Abstract] [Full Text] [Related]

  • 18. Problems in daily motor performances in Parkinson's disease: the continuous dopaminergic stimulation.
    Stocchi F, Ruggieri S, Brughitta G, Agnoli A.
    J Neural Transm Suppl; 1986 Sep; 22():209-18. PubMed ID: 3465872
    [Abstract] [Full Text] [Related]

  • 19. The hypothesis of the genesis of motor complications and continuous dopaminergic stimulation in the treatment of Parkinson's disease.
    Stocchi F.
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S9-S15. PubMed ID: 19131046
    [Abstract] [Full Text] [Related]

  • 20. Comparison between L-dopa and lisuride intravenous infusions: a clinical study.
    Ruggieri S, Stocchi F, Carta A, Bravi D, Bragoni M, Giorgi L, Agnoli A.
    Mov Disord; 1988 Jan; 3(4):313-9. PubMed ID: 3211176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.